Sherris Pharma Partners

Sherris Pharma Partners is a strategic advisory and consulting firm specializing in the biopharmaceutical industry. Founded and led by Dr. David Sherris, a serial biotech entrepreneur, the firm provides expertise in business development, R&D strategy, and venture financing. With a niche focus on angiogenesis, vascular targeting, and oncology, Sherris Pharma Partners assists early-stage biotechnology companies and venture capital groups in advancing therapeutic programs and securing capital. Dr. Sherris's extensive background includes founding Paloma Pharmaceuticals and serving as CEO of Attivare Therapeutics, where he has overseen the development of novel therapies such as the PI3K/Akt/mTOR inhibitor RES-529.